Correction: Randomization in the age of platform trials: unexplored challenges and some potential solutions

BMC Medical Research Methodology, vol. 26, pp. 25

Authors 13

1. Olga M. Kuznetsova

   Merck & Co., Inc., Rahway, NJ, USA (United States)

   Affiliation as printed

   Merck & Co., Inc, Rahway, NJ, USA

2. Jennifer Ross
   Affiliation as printed

   Almac Group, Souderton, PA, USA

3. Daniel Bodden Aachen

   RWTH Aachen University

   Affiliation as printed

   RWTH Aachen University, Aachen, Germany

4. Freda Cooner

   United States Food and Drug Administration

   Affiliation as printed

   Food and Drug Administration, Silver Spring, MD, USA

5. Jonathan Chipman

   University of Utah

   Affiliation as printed

   University of Utah School of Medicine, Salt Lake City, UT, USA

6. Peter Jacko

   Lancaster University

   Affiliation as printed

   Berry Consultants, Lancaster University, Abingdon, Lancaster, Oxfordshire, UK

7. Johannes Krisam

   Boehringer Ingelheim (Germany)

   Affiliation as printed

   Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany

8. Yuqun Luo

   United States Food and Drug Administration

   Affiliation as printed

   Food and Drug Administration, Silver Spring, MD, USA

9. Tobias Mielke
   Affiliation as printed

   Janssen-Cilag GmbH, Neuss, Germany

10. Yevgen V. Ryeznik corresponding

    Uppsala University

    Affiliation as printed

    Department of Mathematics, Uppsala University, Uppsala, Sweden. yevgen.ryeznik@math.uu.se

11. Sofía S. Villar

    University of Cambridge · MRC Biostatistics Unit

    Affiliation as printed

    MRC Biostatistics Unit, University of Cambridge, Cambridge, UK

12. Wenle Zhao

    Medical University of South Carolina

    Affiliation as printed

    Medical University of South Carolina, Charleston, SC, USA

13. Oleksandr Sverdlov corresponding
    Affiliation as printed

    Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. alex.sverdlov@novartis.com